Share This Article:

Usefulness of new live 3D ultrasound probe during radiofrequency ablation in a case of hepatocellular carcinoma

Full-Text HTML Download Download as PDF (Size:942KB) PP. 15-17
DOI: 10.4236/ojgas.2012.21003    4,362 Downloads   6,751 Views   Citations

ABSTRACT

We report a case of hepatocellular carcinoma (HCC) with chronic hepatitis C virus (HCV) infection, suc-cessfully treated with percutaneous radiofrequency ablation (RFA) under new Live trhree-dimensional (3D) echo guidance for hearts probe before [1], but ,at the time, perform RFA with a new Live3D probe de- veloped flants. A 61 year-old Japanese man had a 3.5 cm in diameter HCC nodule in the liver S3 region. We applied the Live 3D ultrasonography during RFA therapy with a cool-tip needle electrode. The echo guidance facilitated an accurate approach for the needle puncture. The guidance was also useful for confirming, whether an adequate safety marging for the nodule had been obtained. Thus new Live 3D ul-trasonography echo technique appears to provide safe guidance of RFA needles via accurate targeting of HCC nodules, thereby allowing real-time visualize- tion when combined with echo contrast.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Hotta, N. and Masuko, K. (2012) Usefulness of new live 3D ultrasound probe during radiofrequency ablation in a case of hepatocellular carcinoma. Open Journal of Gastroenterology, 2, 15-17. doi: 10.4236/ojgas.2012.21003.

References

[1] Hotta, N., Ayada, M., Okumura, A., Ishikawa, T. and Ka- kumu, S., (2007) Usefulness of live 3D echocardiography during radiofrequency ablation in a case of hepatocellular carcinoma. Clinical Imaging, 31, 283-286. doi:10.1016/j.clinimag.2007.01.009
[2] El-Serag, H.B. and Mason, A.C. (1999) Rising incidence of hepatocellular carci-noma in the United States. The New England Journal of Medi-cine, 340, 745-750. doi:10.1056/NEJM199903113401001
[3] Taylor-Robinson, S.D., Foster, G.R., Arora, S., Hargreaves, S. and Thomas, H.C. (1997) Increase in primary liver cancer in the UK 1979-94. Lancet, 350, 1142-1143. doi:10.1016/S0140-6736(05)63789-0
[4] Shiratori, Y., Shiina, S., Imamura, M., Kato, N., Knai, F., Okudaira T., Teratani, T., Tohgo, G., Toda, N. and Omata, M. (1995) Characteristic dif-ference of hepatocelluar carcinoma between hepatitis B- and C- viral infection in Japan. Hepatology, 22, 1027-1033. doi:10.1002/hep.1840220403
[5] Livraghi, T., Lazzaroni, S. and Meloni, F. (2001) Radiof- requency thermal ablation of hepatocellular carcinoma. European Journal of Ultarasound, 13, 159-166. doi:10.1016/S0929-8266(01)00128-8
[6] Hotta, N., Maeno, T., Ayada, M., Sato, K., Ishikawa, T., Okumura, A., Matsumoto, E., Fukuzawa, Y. and Kakumu, S. (2006) Four-dimensional ultrasonography for thera- peutic radiofrequency ablation for hepatocellular carcino- ma. Hepato-Gastroenterology, 53, 521-525.
[7] Wen, L., Numata, K., Morimoto, M., Kondo, M., Takebayashi, S., Morita, S. and Tanaka, K. (2009) Focal Liver Tumors: Characterization with 3D perflubutane microbubble contrast agent; enhanced US versus 3D contrast- enhanced multidetector CT. Radiology, 251, 287-295. doi:10.1148/radiol.2511081324
[8] Numata, K., Luo, W., Morimoto, M., Kondom M., Ku- nishi, Y., Sasaki, T., Nozaki, A. and Tanaka, K. (2010) Contrast enhanced ultrasound of hepatocellular carcino- ma. World Journal of Radiology, 28, 68-82. doi:10.4329/wjr.v2.i2.68

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.